Literature DB >> 21488858

In-vivo purging of the circulating clonal T-cells with Alemtuzumab prior to autologous peripheral blood hematopoietic cell mobilization and transplantation.

Andrei Shustov, Sindhu Cherian, Allison Shaw, Toni-Ann Lupinacci, David Maloney, Leona Holmberg, Ajay K Gopal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21488858     DOI： 10.1111/j.1365-2141.2011.08619.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  2 in total

1.  Minimal detectable disease confirmed by flow cytometry and poor outcome after autologous stem cell transplantation in peripheral T-Cell lymphomas.

Authors:  J Gauthier; L Holmberg; D Wu; W Bensinger; A K Gopal; O Press; D Maloney; D J Green; B G Till; D Byelykh; A Shustov
Journal:  Bone Marrow Transplant       Date:  2016-10-24       Impact factor: 5.483

Review 2.  Hematopoietic stem cell therapy for multiple sclerosis: top 10 lessons learned.

Authors:  Harold L Atkins; Mark S Freedman
Journal:  Neurotherapeutics       Date:  2013-01       Impact factor: 7.620
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.